|
|
重症肺炎的病原学诊断进展
|
Abstract:
重症肺炎是一种病情严重、治疗复杂且死亡率相对较高的呼吸系统疾病。近年来，尽管其发病率及死亡率有所下降，但早期诊断，尤其是病原学诊断，仍是提高重症肺炎救治能力的关键环节。随着全球新冠病毒的流行，重症肺炎的病原学谱发生了相应变化。分子诊断技术的使用在过去十年中有所增加，这些技术有助于在一个呼吸道样本中检测多种病毒，使得严重CAP中呼吸道病毒的报告频率越来越高。未来，随着科技的不断进步和医疗技术的不断创新，CAP及SCAP的诊断及治疗将取得更多进展，为患者提供更加精准、有效的治疗服务。本文综述了近年来重症肺炎病原学诊断的最新进展，旨在为提高重症肺炎的救治能力提供参考。
Severe community-acquired pneumonia has a complex condition, high treatment costs, and a high mortality rate, posing a great threat to human life and health. In recent years, although its incidence rate and mortality have declined, early diagnosis, especially etiological diagnosis, is still the key link to improve the rescue ability of severe community-acquired pneumonia. With the global prevalence of COVID-19, the pathogenic spectrum of severe pneumonia has changed accordingly. The use of molecular diagnostic techniques has increased in the past decade, which helps detect multiple viruses in a respiratory sample, leading to an increasing frequency of reporting respiratory viruses in severe CAP. In the future, with the continuous advancement of technology and innovation in medical technology, more progress will be made in the diagnosis and treatment of CAP and SCAP, providing patients with more accurate and effective treatment services. This article reviews the latest advances in the etiological diagnosis of severe community-acquired pneumonia in recent years, aiming to provide a reference for improving the treatment capacity of severe community-acquired pneumonia.
| [1] | Mandell, L.A., Wunderink, R.G., Anzueto, A., Bartlett, J.G., Campbell, G.D., Dean, N.C., et al. (2007) Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases, 44, S27-S72. https://doi.org/10.1086/511159 |
| [2] | Liapikou, A., Ferrer, M., Polverino, E., Balasso, V., Esperatti, M., Piñer, R., et al. (2009) Severe Community‐Acquired Pneumonia: Validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission. Clinical Infectious Diseases, 48, 377-385. https://doi.org/10.1086/596307 |
| [3] | Phua, J., See, K.C., Chan, Y.H., Widjaja, L.S., Aung, N.W., Ngerng, W.J., et al. (2009) Validation and Clinical Implications of the IDSA/ATS Minor Criteria for Severe Community-Acquired Pneumonia. Thorax, 64, 598-603. https://doi.org/10.1136/thx.2009.113795 |
| [4] | Brown, S.M., Jones, B.E., Jephson, A.R. and Dean, N.C. (2009) Validation of the Infectious Disease Society of America/American Thoracic Society 2007 Guidelines for Severe Community-Acquired Pneumonia. Critical Care Medicine, 37, 3010-3016. https://doi.org/10.1097/ccm.0b013e3181b030d9 |
| [5] | Chalmers, J.D., Taylor, J.K., Mandal, P., Choudhury, G., Singanayagam, A., Akram, A.R., et al. (2011) Validation of the Infectious Diseases Society of America/American Thoratic Society Minor Criteria for Intensive Care Unit Admission in Community-Acquired Pneumonia Patients without Major Criteria or Contraindications to Intensive Care Unit Care. Clinical Infectious Diseases, 53, 503-511. https://doi.org/10.1093/cid/cir463 |
| [6] | Marti, C., Garin, N., Grosgurin, O., Poncet, A., Combescure, C., Carballo, S., et al. (2012) Prediction of Severe Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis. Critical Care, 16, Article No. R141. https://doi.org/10.1186/cc11447 |
| [7] | 中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版) [J]. 中华结核和呼吸杂志, 2016, 39(4): 253-279. |
| [8] | Fine, M.J., Auble, T.E., Yealy, D.M., Hanusa, B.H., Weissfeld, L.A., Singer, D.E., et al. (1997) A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia. New England Journal of Medicine, 336, 243-250. https://doi.org/10.1056/nejm199701233360402 |
| [9] | Lim, W.S. (2003) Defining Community Acquired Pneumonia Severity on Presentation to Hospital: An International Derivation and Validation Study. Thorax, 58, 377-382. https://doi.org/10.1136/thorax.58.5.377 |
| [10] | España, P.P., Capelastegui, A., Gorordo, I., Esteban, C., Oribe, M., Ortega, M., et al. (2006) Development and Validation of a Clinical Prediction Rule for Severe Community-Acquired Pneumonia. American Journal of Respiratory and Critical Care Medicine, 174, 1249-1256. https://doi.org/10.1164/rccm.200602-177oc |
| [11] | Shen, B., Yi, X., Sun, Y., Bi, X., Du, J., Zhang, C., et al. (2020) Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell, 182, 59-72.e15. https://doi.org/10.1016/j.cell.2020.05.032 |
| [12] | 周雨蒙, 张铁栓, 邵润霞, 等. 重症肺炎患者的病原学特点及预后相关因素分析[J]. 中国现代医生, 2023, 61(33): 41-44. |
| [13] | Erdoğan, M. and Findikli, H.A. (2022) Prognostic Value of the Lactate/Albumin Ratio for Predicting Mortality in Patients with Pneumosepsis in Intensive Care Units. Medicine, 101, e28748. https://doi.org/10.1097/md.0000000000028748 |
| [14] | Wilson, M.R., Naccache, S.N., Samayoa, E., Biagtan, M., Bashir, H., Yu, G., et al. (2014) Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing. New England Journal of Medicine, 370, 2408-2417. https://doi.org/10.1056/nejmoa1401268 |
| [15] | Li, N., Cai, Q., Miao, Q., Song, Z., Fang, Y. and Hu, B. (2020) High‐Throughput Metagenomics for Identification of Pathogens in the Clinical Settings. Small Methods, 5, Article ID: 2000792. https://doi.org/10.1002/smtd.202000792 |
| [16] | 编辑委员会中华传染病杂志. 中国宏基因组学第二代测序技术检测感染病原体的临床应用专家共识[J]. 中华传染病杂志, 2020, 38(11): 681-689. |
| [17] | 张怡欣, 甘桂芬. mNGS在重症肺炎中的应用[J]. 临床医学进展, 2022, 12(10): 8978-8982. |
| [18] | 中华医学会检验医学分会临床微生物学组, 中华医学会微生物学与免疫学分会临床微生物学组, 中国医疗保健国际交流促进会临床微生物与感染分会. 宏基因组高通量测序技术应用于感染性疾病病原检测中国专家共识[J]. 中华检验医学杂志, 2021, 44(2): 107-120. |
| [19] | 宏基因组学测序技术在中重症感染中的临床应用共识专家组, 中国研究型医院学会脓毒症与休克专业委员会, 中国微生物学会微生物毒素专业委员会, 等. 宏基因组学测序技术在中重症感染中的临床应用专家共识(第一版) [J]. 感染、炎症、修复, 2020, 21(2): 75-81. |
| [20] | Gaston, D.C., Miller, H.B., Fissel, J.A., Jacobs, E., Gough, E., Wu, J., et al. (2022) Evaluation of Metagenomic and Targeted Next-Generation Sequencing Workflows for Detection of Respiratory Pathogens from Bronchoalveolar Lavage Fluid Specimens. Journal of Clinical Microbiology, 60, e52622. https://doi.org/10.1128/jcm.00526-22 |
| [21] | Li, S., Tong, J., Liu, Y., Shen, W. and Hu, P. (2022) Targeted Next Generation Sequencing Is Comparable with Metagenomic Next Generation Sequencing in Adults with Pneumonia for Pathogenic Microorganism Detection. Journal of Infection, 85, e127-e129. https://doi.org/10.1016/j.jinf.2022.08.022 |
| [22] | 葛哲, 付仕忠. 靶向高通量测序技术在肺炎病原学诊断中的应用进展[J]. 现代临床医学, 2024, 50(5): 375-377. |
| [23] | 陈华, 陈品儒, 李艳阳, 等. 靶向高通量测序鉴定非结核分枝杆菌菌种的应用价值[J]. 中国防痨杂志, 2023, 45(4): 362-366. |
| [24] | 张欢欢, 李牛, 郁婷婷, 等. 靶向基因高通量测序技术诊断儿童基因组病的可行性研究[J]. 上海交通大学学报(医学版), 2016, 36(9): 1301-1305. |
| [25] | 马占忠, 许红雁, 胡红波, 等. 靶向高通量测序检测卵巢癌患者易感基因突变与临床特征的相关性研究[J]. 现代检验医学杂志, 2021, 36(6): 111-115. |
| [26] | Haessler, S., Guo, N., Deshpande, A., Zilberberg, M.D., Lagu, T., Lindenauer, P.K., et al. (2022) Etiology, Treatments, and Outcomes of Patients with Severe Community-Acquired Pneumonia in a Large U.S. Sample. Critical Care Medicine, 50, 1063-1071. https://doi.org/10.1097/ccm.0000000000005498 |
| [27] | Cavallazzi, R., Furmanek, S., Arnold, F.W., Beavin, L.A., Wunderink, R.G., Niederman, M.S., et al. (2020) The Burden of Community-Acquired Pneumonia Requiring Admission to ICU in the United States. Chest, 158, 1008-1016. https://doi.org/10.1016/j.chest.2020.03.051 |
| [28] | Carugati, M., Aliberti, S., Sotgiu, G., Blasi, F., Gori, A., Menendez, R., et al. (2020) Bacterial Etiology of Community-Acquired Pneumonia in Immunocompetent Hospitalized Patients and Appropriateness of Empirical Treatment Recommendations: An International Point-Prevalence Study. European Journal of Clinical Microbiology & Infectious Diseases, 39, 1513-1525. https://doi.org/10.1007/s10096-020-03870-3 |
| [29] | Huang, W., Lee, C., Wu, M., Huang, C., Hsu, C., Chen, H., et al. (2018) Clinical Features, Bacteriology of Endotracheal Aspirates and Treatment Outcomes of Patients with Chronic Obstructive Pulmonary Disease and Community-Acquired Pneumonia in an Intensive Care Unit in Taiwan with an Emphasis on Eosinophilia versus Non-Eosinophilia: A Retrospective Case-Control Study. BMJ Open, 8, e020341. https://doi.org/10.1136/bmjopen-2017-020341 |
| [30] | Restrepo, M.I., Babu, B.L., Reyes, L.F., Chalmers, J.D., Soni, N.J., Sibila, O., et al. (2018) Burden and Risk Factors for Pseudomonas aeruginosa Community-Acquired Pneumonia: A Multinational Point Prevalence Study of Hospitalised Patients. European Respiratory Journal, 52, Article ID: 1701190. https://doi.org/10.1183/13993003.01190-2017 |
| [31] | Cillóniz, C., Torres, A. and Niederman, M.S. (2021) Management of Pneumonia in Critically Ill Patients. BMJ, 375, e065871. https://doi.org/10.1136/bmj-2021-065871 |
| [32] | Prina, E., Ranzani, O.T., Polverino, E., Cillóniz, C., Ferrer, M., Fernandez, L., et al. (2015) Risk Factors Associated with Potentially Antibiotic-Resistant Pathogens in Community-Acquired Pneumonia. Annals of the American Thoracic Society, 12, 153-160. https://doi.org/10.1513/annalsats.201407-305oc |
| [33] | Qin, X., Huang, J., Yang, Z., Sun, X., Wang, W., Gong, E., et al. (2022) Severe Community-Acquired Pneumonia Caused by chlamydia Psittaci Genotype E/B Strain Circulating among Geese in Lishui City, Zhejiang Province, China. Emerging Microbes & Infections, 11, 2715-2723. https://doi.org/10.1080/22221751.2022.2140606 |
| [34] | Xing, F., Chiu, K.H., Deng, C., Ye, H., Sun, L., Su, Y., et al. (2024) Post-COVID-19 Pandemic Rebound of Macrolide-Resistant Mycoplasma Pneumoniae Infection: A Descriptive Study. Antibiotics, 13, Article 262. https://doi.org/10.3390/antibiotics13030262 |
| [35] | Herwaldt, L.A. and Marra, A.R. (2018) Legionella: A Reemerging Pathogen. Current Opinion in Infectious Diseases, 31, 325-333. https://doi.org/10.1097/qco.0000000000000468 |
| [36] | Chen, J., Li, X., Wang, W., Jia, Y., Lin, F. and Xu, J. (2019) The Prevalence of Respiratory Pathogens in Adults with Community-Acquired Pneumonia in an Outpatient Cohort. Infection and Drug Resistance, 12, 2335-2341. https://doi.org/10.2147/idr.s213296 |
| [37] | Tao, L.L., Hu, B.J., He, L.X., et al. (2012) Etiology and Antimicrobial Resistance of Community-Acquired Pneumonia in Adult Patients in China. Chinese Medical Journal, 125, 2967-2972. |
| [38] | Wang, L., Cao, J., Xia, B., Li, Y., Zhang, X., Mo, G., et al. (2023) Metatranscriptome of Human Lung Microbial Communities in a Cohort of Mechanically Ventilated COVID-19 Omicron Patients. Signal Transduction and Targeted Therapy, 8, Article No. 432. https://doi.org/10.1038/s41392-023-01684-1 |
| [39] | Palmieri, F., Koutsokera, A., Bernasconi, E., Junier, P., von Garnier, C. and Ubags, N. (2022) Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies with a Focus on Aspergillus spp. Frontiers in Medicine, 9, Article 832510. https://doi.org/10.3389/fmed.2022.832510 |
| [40] | Green, H., Paul, M., Vidal, L., et al. (2014) Prophylaxis for Pneumocystis pneumonia (PCP) in Non-HIV Immunocompromised Patients. Cochrane Database of Systematic Reviews, 10, CD5590. |
| [41] | 孙秋霞, 王静, 兰箭. 人类免疫缺陷病毒阴性重症肺孢子菌肺炎的诊治进展[J]. 中国药业, 2023, 32(6): 128-133. |
| [42] | Szydłowicz, M. and Matos, O. (2021) Pneumocystis Pneumonia in the COVID-19 Pandemic Era: Similarities and Challenges. Trends in Parasitology, 37, 859-862. https://doi.org/10.1016/j.pt.2021.07.010 |
| [43] | Liu, K., Ding, H., Xu, B., You, R., Xing, Z., Chen, J., et al. (2016) Clinical Analysis of Non-Aids Patients Pathologically Diagnosed with Pulmonary Cryptococcosis. Journal of Thoracic Disease, 8, 2813-2821. https://doi.org/10.21037/jtd.2016.10.36 |
| [44] | 彭晓露, 彭玫, 杜婷婷, 等. 重症肺炎发生肺部真菌感染的危险因素[J]. 国际呼吸杂志, 2023, 43(1): 68-74. |
| [45] | Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., et al. (2020) Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. The Lancet, 395, 507-513. https://doi.org/10.1016/s0140-6736(20)30211-7 |
| [46] | 程中乐, 魏薇, 吴承煦, 等. 支气管肺泡灌洗液半乳甘露聚糖检测在COVID-19相关侵袭性肺部真菌感染中的诊断价值[J]. 中国临床研究, 2023, 36(9): 1366-1369. |
| [47] | Zhou, X., Wu, X., Chen, Z., Cui, X., Cai, Y., Liu, Y., et al. (2023) Risk Factors and the Value of Microbiological Examinations of COVID-19 Associated Pulmonary Aspergillosis in Critically Ill Patients in Intensive Care Unit: The Appropriate Microbiological Examinations Are Crucial for the Timely Diagnosis of Capa. Frontiers in Cellular and Infection Microbiology, 13, Article 1287496. https://doi.org/10.3389/fcimb.2023.1287496 |
| [48] | Ren, H., Zhao, Q., Jiang, J., Yang, W., Fu, A. and Ge, Y. (2023) Acute Heart Failure Due to Pulmonary Aspergillus Fumigatus and Cryptococcus Neoformans Infection Associated with COVID-19. Clinical Laboratory, 69, 2011-2016. https://doi.org/10.7754/clin.lab.2023.230407 |
